triazoles has been researched along with Retinoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dokala, A; Gurrapu, N; Kolluri, PK; Praveenkumar, E; Subhashini, NJP | 1 |
| Duan, S; Huang, G; Jang, A; Liu, X; Mao, L; Zhang, Y | 1 |
2 other study(ies) available for triazoles and Retinoblastoma
| Article | Year |
|---|---|
Selective CDK4/6 inhibition of novel 1,2,3-triazole tethered acridinedione derivatives induces G1/S cell cycle transition arrest via Rb phosphorylation blockade in breast cancer models.
Topics: Acridines; Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Dose-Response Relationship, Drug; Female; Humans; Models, Molecular; Molecular Structure; Phosphorylation; Protein Kinase Inhibitors; Retinoblastoma; Structure-Activity Relationship; Triazoles | 2021 |
JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azepines; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Real-Time Polymerase Chain Reaction; Retinal Neoplasms; Retinal Pigment Epithelium; Retinoblastoma; RNA, Messenger; Signal Transduction; Transcription Factors; Triazoles | 2021 |